Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED95 dose of remimazolam for induction of general anesthesia in elderly patients
ChiCTR2200060256Phase 4Not yet recruiting
- Sponsor
- Renmin Hospital of Wuhan University
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of remimazolam, sponsored by Renmin Hospital of Wuhan University. Primary endpoint: success rate of sedation. Planned start May 2022; status: not yet recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2200060256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060256.